Atlas Trials

Efficacy and Immunomodulation Study of Simultaneous Human Papillomavirus/ Hepatitis B (HPV/HBV) Vaccination

Clinical trial NCT01082861 · TERMINATED

Trial details

NCT number
NCT01082861
Sponsor
National Institute for Public Health and the Environment (RIVM)
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Human Papillomavirus Infection
Start date
2010-09-01
Primary completion
2011-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.